Bagwan[1717 Bagwan IN, Desai S, Wotherspoon A, Sheppard MN. Unusual presentation of primary cardiac lymphoma. Interact Cardiovasc Thorac Surg. 2009;9(1):127-9. doi:10.1510/icvts.2009.204628. https://doi.org/10.1510/icvts.2009.20462...
] |
Left atrium (4 × 2 cm) |
Multiple strokes |
Diffuse large B-cell lymphoma |
Not available |
Gelatinous, grape-like, friable |
Not available |
Dimitrova[1818 Dimitrova KR, Hoffman DM, Geller CM, Thiagarjah P, Master J, Berger M, et al. Malignant B-cell lymphoma arising in a large, left atrial myxoma. Ann Thorac Surg. 2010;89(2):626-9. doi:10.1016/j.athoracsur.2009.06.096. https://doi.org/10.1016/j.athoracsur.200...
] |
Left atrium (7.5 × 4.5 cm) |
Chest pain |
Diffuse large B-cell lymphoma |
Not available |
Partially fimbriated surface, gelatinous and necrotic parts |
Not available |
Loong[1111 Loong F, Chan AC, Ho BC, Chau YP, Lee HY, Cheuk W, et al. Diffuse large B-cell lymphoma associated with chronic inflammation as an incidental finding and new clinical scenarios. Mod Pathol. 2010;23(4):493-501. doi:10.1038/modpathol.2009.168. https://doi.org/10.1038/modpathol.2009.1...
] |
Left atrium (6.5 × 4 cm) |
Cardiogenic shock, ischemic stroke |
Diffuse large B-cell lymphoma |
Type III latency (EBER+, LMP1+) |
Not described |
Patient deceased for chemotherapy complications (neutropenia + pneumonia) at 5 months |
Svec[1212 Svec A, Rangaiah M, Giles M, Jaksa R, McAulay KA. EBV+ diffuse large B-cell lymphoma arising within atrial myxoma. An example of a distinct primary cardiac EBV+ DLBCL of immunocompetent patients. Pathol Res Pract. 2012;208(3):172-6.] |
Left atrium (3.7 × 1.5 cm) |
Ischemic stroke |
Diffuse large B-cell lymphoma |
Type III latency (EBER +, LMP1+) |
Not described |
No evidence of disease at 7 months |
Bartoloni[1313 Bartoloni G, Pucci A, Giorlandino A, Berretta M, Mignosa C, Italia F, et al. Incidental Epstein-Barr virus associated atypical lymphoid proliferation arising in a left atrial myxoma: a case of long survival without any postsurgical treatment and review of the literature. Cardiovasc Pathol. 2013;22(3):e5-10. doi:10.1016/j.carpath.2012.08.002. https://doi.org/10.1016/j.carpath.2012.0...
] |
Left atrium (5.5 × 4.5 cm) |
Fever and progressive fatigue |
Atypical lymphoid B-cell proliferation |
Type II latency (EBER +, LMP1+) |
Glistening, villous and gelatinous surface |
No evidence of disease at 72 months |
Tapan[1515 Tapan U, Pestana JB, Lee JC, Lerner A. Epstein-Barr virus-associated diffuse large B-cell lymphoma arising in atrial myxoma: a proposal for a modified therapeutic approach. Leuk Lymphoma. 2015;56(2):505-7. doi:10.3109/10428194.2014.919632. https://doi.org/10.3109/10428194.2014.91...
] |
Left atrium (4.2 × 3.6 cm) |
Palpitations |
Diffuse large B-cell lymphoma |
Type III latency (EBER +, LMP1+) |
Not described |
No evidence of disease at 12 months |
Aguilar[1414 Aguilar C, Beltran B, Quiñones P, Carbajal T, Vilcapaza J, Yabar A, et al. Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus? Cardiovasc Pathol. 2015;24(1):60-4. doi:10.1016/j.carpath.2014.08.007. https://doi.org/10.1016/j.carpath.2014.0...
] |
Left atrium (6 × 2.5 cm) |
Transient ischemic attack |
Diffuse large B-cell lymphoma |
Type III latency (EBER +, LMP1+) |
Not described |
No evidence of disease at 42 months |
Pineda[33 Pineda AM, Mihos CG, Nascimento FO, Santana O, Lamelas J, Beohar N. Coronary embolization from a left atrial myxoma containing malignant lymphoma cells. Tex Heart Inst J. 2015;42(6):565-8. doi:10.14503/THIJ-14-4619. https://doi.org/10.14503/THIJ-14-4619...
] |
Left atrium (6.5 × 3 cm) |
Coronary embolization |
Diffuse large B-cell lymphoma |
Not available |
Reddish, gelatinous |
Not available |
Park[2020 Park CK, Cho YA, Kim M, Shim HS. Malignant lymphoma arising in cardiac myxoma, presenting with peripheral arterial emboli. Cardiovasc Pathol. 2018;32:26-9. doi:10.1016/j.carpath.2017.10.001. https://doi.org/10.1016/j.carpath.2017.1...
] |
Left atrium (6 × 3.2 cm) |
Peripheral arterial embolization |
Diffuse large B-cell lymphoma |
Type III latency, EBER + |
Irregular surface, friable |
Not available |
Boyer[99 Boyer DF, McKelvie PA, de Leval L, Edlefsen KL, Ko YH, Aberman ZA, et al. Fibrin-associated EBV-positive large B-cell lymphoma: an indolent neoplasm with features distinct from diffuse large B-cell lymphoma associated with chronic inflammation. Am J Surg Pathol. 2017;41(3):299-312. doi:10.1097/PAS.0000000000000775. https://doi.org/10.1097/PAS.000000000000...
] |
Left atrium (? cm) |
Syncope |
Diffuse large B-cell lymphoma |
EBER+ |
Not available |
No evidence of disease at 130 months |
Boyer[99 Boyer DF, McKelvie PA, de Leval L, Edlefsen KL, Ko YH, Aberman ZA, et al. Fibrin-associated EBV-positive large B-cell lymphoma: an indolent neoplasm with features distinct from diffuse large B-cell lymphoma associated with chronic inflammation. Am J Surg Pathol. 2017;41(3):299-312. doi:10.1097/PAS.0000000000000775. https://doi.org/10.1097/PAS.000000000000...
] |
Left atrium (? cm) |
Syncope, cough, dyspnoea |
Diffuse large B-cell lymphoma |
EBER+, LMP1+ |
Reddish, gelatinous |
Patient died at 2 months for cardiac cause |
Boyer[99 Boyer DF, McKelvie PA, de Leval L, Edlefsen KL, Ko YH, Aberman ZA, et al. Fibrin-associated EBV-positive large B-cell lymphoma: an indolent neoplasm with features distinct from diffuse large B-cell lymphoma associated with chronic inflammation. Am J Surg Pathol. 2017;41(3):299-312. doi:10.1097/PAS.0000000000000775. https://doi.org/10.1097/PAS.000000000000...
] |
Left atrium (? cm) |
Dyspnoea, respiratory failure |
Diffuse large B-cell lymphoma |
EBER+, LMP1+ |
Not available |
Recurrent FA-DLBCL at mitral valve after 25 months. Patient died at 26 months (embolic stroke). |
Yan[1010 Yan J, Luo D, Zhang F, He J, Yao S, Luo X, et al. Diffuse large B cell lymphoma associated with chronic inflammation arising within atrial myxoma: aggressive histological features but indolent clinical behaviour. Histopathology. 2017;71(6):951-9. doi:10.1111/his.13336. https://doi.org/10.1111/his.13336...
] |
Left atrium (? cm) |
Congestive heart failure |
Diffuse large B-cell lymphoma |
Type III latency, EBER+, LMP1+ |
Myxoid appearance with an abundant fibrinous or mucinous background in the centre |
No evidence of disease at 7 months |
Yan[1010 Yan J, Luo D, Zhang F, He J, Yao S, Luo X, et al. Diffuse large B cell lymphoma associated with chronic inflammation arising within atrial myxoma: aggressive histological features but indolent clinical behaviour. Histopathology. 2017;71(6):951-9. doi:10.1111/his.13336. https://doi.org/10.1111/his.13336...
] |
Left atrium (? cm) |
Congestive heart failure |
Diffuse large B-cell lymphoma |
Type III latency, EBER+, LMP1+ |
Myxoid appearance with an abundant fibrinous or mucinous background in the centre |
No evidence of disease at 84 months |
Yan[1010 Yan J, Luo D, Zhang F, He J, Yao S, Luo X, et al. Diffuse large B cell lymphoma associated with chronic inflammation arising within atrial myxoma: aggressive histological features but indolent clinical behaviour. Histopathology. 2017;71(6):951-9. doi:10.1111/his.13336. https://doi.org/10.1111/his.13336...
] |
Left atrium (? cm) |
Congestive heart failure |
Diffuse large B-cell lymphoma |
Type III latency, EBER+, LMP1+ |
Myxoid appearance with an abundant fibrinous or mucinous background in the centre |
No evidence of disease at 3 months |
Yan[1010 Yan J, Luo D, Zhang F, He J, Yao S, Luo X, et al. Diffuse large B cell lymphoma associated with chronic inflammation arising within atrial myxoma: aggressive histological features but indolent clinical behaviour. Histopathology. 2017;71(6):951-9. doi:10.1111/his.13336. https://doi.org/10.1111/his.13336...
] |
Left atrium (? cm) |
Congestive heart failure |
Diffuse large B-cell lymphoma |
Type III latency, EBER+, LMP1+ |
Myxoid appearance with an abundant fibrinous or mucinous background in the centre |
No evidence of disease at 120 months |
Present case |
Left atrium (3.6 × 3 cm) |
Asthenia, dyspnoea and dizziness |
Diffuse large B-cell lymphoma |
EBER+, LMP1+ |
Gelatinous, grape-like, pale pink, semi-transparent, extremely friable |
No evidence of disease at 4 months |